ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.

Saved in:
Bibliographic Details
Title: ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.
Authors: Jain L; Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA., Khrestian M; Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA., Formica S; Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA., Tuason ED; Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA., Pillai JA; Cleveland Clinic Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, Ohio, USA., Rao S; Cleveland Clinic Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, Ohio, USA., Oguh O; Cleveland Clinic Lou Ruvo Center for Brain Health-Las Vegas, Cleveland Clinic, Las Vegas, Nevada, USA., Lippa CF; Cleveland Clinic Lou Ruvo Center for Brain Health-Las Vegas, Cleveland Clinic, Las Vegas, Nevada, USA., Lopez OL; Cognitive Disorders & Comprehensive Alzheimer's Disease Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Berman SB; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Tsuang DW; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, USA.; Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, USA., Zabetian CP; Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, USA.; Department of Neurology, University of Washington School of Medicine, Seattle, Washington, USA., Irwin DJ; Department of Neurology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.; Digital Neuropathology Laboratory, Philadelphia, Pennsylvania, USA.; Lewy Body Disease Research Center of Excellence, Philadelphia, Pennsylvania, USA.; Frontotemporal Degeneration Center, Philadelphia, Pennsylvania, USA., Galasko DR; Department of Neurosciences, University of California, San Diego, California, USA., Litvan I; Department of Neurosciences, University of California, San Diego, California, USA., Marder KS; Columbia University Irving Medical Center, New York, New York, USA., Honig LS; Department of Neurosciences, University of California, San Diego, California, USA., Fleisher JE; Department of Neurological Sciences, Rush Medical College, Chicago, Illinois, USA., Galvin JE; Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Miami, Florida, USA., Bozoki AC; Department of Neurology, University of North Carolina, Chapel Hill, North Carolina, USA., Taylor AS; Lewy Body Dementia Association, Lilburn, Georgia, USA., Sabbagh MN; Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA., Leverenz JB; Cleveland Clinic Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, Ohio, USA., Bekris LM; Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Source: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Jan; Vol. 20 (1), pp. 549-562. Date of Electronic Publication: 2023 Sep 23.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1552-5279
DOI:10.1002/alz.13398